Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - BIOSPECIFICS TECHNOLOGIES CORP | bstc-20200930xex31d2.htm |
| EX-31.1 - EX-31.1 - BIOSPECIFICS TECHNOLOGIES CORP | bstc-20200930xex31d1.htm |
| 10-Q - 10-Q - BIOSPECIFICS TECHNOLOGIES CORP | bstc-20200930x10q.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of BioSpecifics Technology Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Joseph Truitt, Principal Executive Officer of the Company, and Patrick Hutchison, Principal Financial Officer of the Company, each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based on each of our knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 9, 2020
| /s/ Joseph Truitt |
| Joseph Truitt |
| Principal Executive Officer |
| |
| /s/ Patrick Hutchison |
| Patrick Hutchison |
| Principal Financial Officer |